rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2011-604rsp-742Research ArticleСтатьиArticlesБОЛЕЗНЬ СТИЛЛА, РАЗВИВШАЯСЯ У ВЗРОСЛЫХAdult-onset Still's diseaseMurav'evYu VMurav'evYu Vmurawyu@mail.ru <mailto:murawyu@mail.ru>НасоновЕвгений ЛьвовичNasonovE Lmurawyu@mail.ruМуравьевЮ. В.MuravyevYu V-НасоновЕвгений ЛьвовичNasonovE L-201115042011492№2 (2011)5865Copyright © Murav'ev Y.V., Насонов Е.Л., Муравьев Ю.В., Насонов Е.Л., 20112011Murav'ev Y.V., Насонов Е.Л., Муравьев Ю.В., Насонов Е.Л.Murav'ev Y.V., Nasonov E.L., Muravyev Y.V., Nasonov E.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/742References<div><p>Международная статистическая классификация болезней и проблем, связанных со здоровьем;10-й пересмотр. Женева: ВОЗ, 1995.</p><p>Efthimiou P., Paik P.K., Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.</p><p>Bannatyne G.A., Wohlmann A.S. Rheumatoid Arthritis: Its clinical history, etiology and pathology. Lancet 1896;1:1120-5.</p><p>Still G.F. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-65.</p><p>Reimann H.A., de Bardinis C.T. Periodic cyclic neutropenia, an entity. Blood 1949;4:1109-16.</p><p>Wissler H. Uber eine besondere Form sepsisahnlicher krankheiten (subsepsishyperergica). Z Kinderheilkd 1964;94:1-23.</p><p>Hegglin R., Uehlinger E. Klinische Demonstrationen: Febris periodica hyperergica. Schweiz Med Wschr 1964;94:675-85.</p><p>Fanconi G. Uber einen Fall von Subsepsis allergica Wissler. Helv Paediatr Acta 1946;1:532-7.</p><p>Riolet J. Syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1964;31:388-97.</p><p>Larson E.B. Adult Still's disease - recognition of a clinical syndrome and recent experience. West J Med 1985;142:665-71.</p><p>Wissler H. Subsepsis allergica. Ergeb Inn Med Kinderheilkd 1965;23:202-20.</p><p>Bywaters E.G. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.</p><p>Bywaters E.G. Categorization in medicine: A survey of Still's disease. Ann Rheum Dis 1967;26:185-93.</p><p>Bujak J.S., Aptekar R.G., Decker J.L. et al. Juvenile rheumatoid arthritis in theadult presenting as fever of unknown origin. Medicine (Baltimore) 1973;52:431-44.</p><p>Fabricant M.S., Chander S.B., Friou G.J. Still's disease in adults: A cause of prolonged undiagnosed fever. JAMA 1973;225:273-5.</p><p>Caroit M., Mathieu M., Kahn M.F. et al. Maladie de Still de l'adulte et syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1973;40:1-8.</p><p>Calabro J.J., Marchesano J.M. Fever associated with juvenile rheumatoid arthritis. N Engl J Med 1967;276:1-18.</p><p>Isdaile I.C., Bywaters E.G. The rash in Still's disease. Quart J Med 1956;25:377-87.</p><p>Calabro J.J., Cruess R.L., Levinson J.E. et al. Juvenile rheumatoid arthritis. Patient Care 1977;11:70-116.</p><p>Elkon K.B., Hughes G.R., Bywaters E.G. et al. Adult onset Still's disease: Twenty-year follow-up and further studies of patients with active disease. Arthr Rheum 1982;25:647-53.</p><p>Medsger T.A., Christy W.C. Carpal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1976;19:232-42.</p><p>Healey L.A., Willkens R.F. Tarsal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1982;25:1254-6.</p><p>Jamieson T.W. Adult Still's disease complicated by cardiac tamponade. JAMA 1983;249:2065-6.</p><p>Tesser J.R., Pisko E.J., Hartz J.W. et al. Chronic liver disease and adult Still's disease. Arthr Rheum 1982;25:579-82.</p><p>Baker D.G., Schumacher H.R., Reginato A.J. Fifteen patients with adult onset Still's disease: Life-threatening liver failure in two (Abstr). Arthr Rheum 1979;22:590.</p><p>Masson C., Le Loët X., Liote F. et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 1995;62:748-57.</p><p>Pelkonen P., Swanliung K., Siimes M.A. Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatr Scand 1986;75:64-8.</p><p>Gonzalez-Hernandez T., Martin-Mola E., Femandez-Zamoeano A. et al. Serum ferritin can be useful for diagnosis in adult onset Still's disease. J Rheumatol 1989;16:412-3.</p><p>Fautrel B., Le Moel G., Saint-Marcoux B. et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001;28:322-9.</p><p>Fautrel B. Ferritin levels in adult Still's disease: any sugar? J Bone Spine 2002;69:355-7.</p><p>Cush J.J. Adult-onset Still's disease. Bull Rheum Dis 2000;49:1-4.</p><p>Van Reeth C., Le Moel G., Lasne Y. et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's dis ease. J Rheumatol 1994;21:890-5.</p><p>Akritidis N., Giannakakis I., Giouglis T. Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol 1996;23:201-2.</p><p>Magadur-Joly G., Billaud E., Barrier J.H. et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 1995;54:587-90.</p><p>Wakai K., Ohta A., Tamakoshi A. et al. Estimated prevalence and incidence of adult Still's disease: findings by anationwide epidemiological survey in Japan. J Epidemiol 1997;7:221-5.</p><p>Ohta A., Yamaguchi M., Tsunematsu T. et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.</p><p>Van de Putte L.B., Wouters J.M. Adultonset Still's disease. Bailliere's Clin Rheumatol 1991;5:263-75.</p><p>Wouters J.M., van de Putte L.B. Adultonset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Quart J Med 1986;61:1055-65.</p><p>Sampalis J.S., Medsger T.A., Fries J.F. et al. Risk factors for adult Still's disease. J Rheumatol 1996;23:2049-54.</p><p>Kontzias A., Efthimiou P. Adult-Onset Still's Disease Pathogenesis, Clinical Manifestations and Therapeutic Advances. Drugs 2008;68:319-37.</p><p>Hoshino T., Ohta A., Yang D. et al. Elevated serum interleukin 6, interferongamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 1998;25:396-8.</p><p>Ogata A., Kitano M., Yamanaka J. et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003;30:1093-6.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Jeon Y.K., Paik J.H., Park S.S. et al. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol 2004;57:1052-6.</p><p>Jamin C., Morva A., Lemoine S. et al. Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthr Rheum 2008;58:1900-6.</p><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.</p><p>Cush J.J., Medsger T. Jr., Christy W.C. et al. Adult-onset Still's disease: clinical course and outcome. Arthr Rheum 1987;30:186-94.</p><p>Fautrel B., Zing E., Golmard J.L. et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194-200.</p><p>Pouchot J., Sampalis J.S., Beaudet F. et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-36.</p><p>Evensen K.J., Nossent H.C. Epidemiology and outcome of adult onset Still's disease in northern Norway. Scand J Rheumatol 2006;35:48-51.</p><p>Pay S., Turkcapar N., Kalyoncu M. et al. A multicenter study of patients with adultonset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006;25:639-44.</p><p>Mandl L., Esdaile J.M. Adult Still's disease. Up To Date. <http://www.uptodate.com/> (accessed 14 February 2006).</p><p>Kaplinsky N., Paas M., Frankl О. An adult form of juvenile rheumatoid arthritis. Arch Intern Med 1980;140:1073-4.</p><p>Khraishi M., Fam A.G. Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol 1991;18:1088-90.</p><p>Bambery P., Thomas R.J., Malhotra H.S. et al. Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 1992;51:529-32.</p><p>Shojania K., Chalmers A., Rangno K. Cyclosporin A in thetreatment of adult Still's disease. J Rheumatol 1995;22:1391-2.</p><p>Cefle A. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother 2005;39:764-7.</p><p>Murakami K., Fujii T., Yukawa N. et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. The Japan Rheum. Association. Modern Rheumatol 2007;17:167-70.</p><p>Mahmud T., Hughes G.R. Intravenous immunoglobulin in thetreatment of refractory adult Still's disease. J Rheumatol 1999;26:2067-8.</p><p>Vignes S., Wechsler B., Amoura Z. et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal antiinflammatory drugs. Clin Exp Rheumatol 1998;16:295-8.</p><p>Bennett A.N., Peterson P., Sangle S. et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 2004;43:795-9.</p><p>Husni M.E., Maier A.L., Mease P.J. et al. Etanercept in the treatment of adult patients with Still's disease. Arthr Rheum 2002;46:1171-6.</p><p>Kuek A., Weerakoon A., Ahmed K. et al. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford) 2007;46:1043-4.</p><p>Cavagna L., Caporali R., Epis O. et al. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001;19:329-32.</p><p>Kokkinos A., Iliopoulos A., Greka P. et al. Successful treatment of refractory adultonset Still's disease with infliximab: a prospective, non-comparative series of four patients. Clin Rheumatol 2004;23:45-9.</p><p>Huffstutter J., Sienknecht C. Treatment of resistant adult Still's disease with infliximab: a report of 2 cases. J Clin Rheumatol 2004;10:218-21.</p><p>Bonilla Hernan M.G., Cobo Ibanez T., de Miguel Mendieta E. et al. Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease: experience in 2 cases [in Spanish]. Ann Med Interna 2004;21:23-6.</p><p>Caramaschi P., Biasi D., Carletto A. et al. A case of adult onset Still's disease treated with infliximab [letter]. Clin Exp Rheumatol 54. 54. 64</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005;64:262-6.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheum 2005;23:733.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of adult onset Still's disease. Semin Arthr Rheum 2006;36:144-52.</p><p>Godinho F., Santos M.J., Canas Da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Fitzgerald A.A., Leclercq S.A., Yan A. et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthr Rheum 2005;52:1794-803.</p><p>Iwamoto M., Nara H., Hirata D. et al. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthr Rheum 2002;46:3388-9.</p><p>Kraetsch H.G., Antoni C., Kalden J.R. et al. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 2001;60(Suppl. 3):55-7.</p><p>Dechant C., Schauenberg P., Antoni C.E. et al. Long-term out come of TNF blockade in adult-onset Still's disease [in German]. Dtsch Med Wschr 2004;129:1308-12.</p><p>Dilhuydy M.S., Vatan R., Etienne G. et al. Prolonged efficacy of infliximab for refractory adult-onset Still's disease. Clin Exp Rheumatol 2005;23:121-2.</p><p>Michel M., Duvoux C., Hezode C. et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003;30:1624-5.</p><p>Olivieri I., de Stefano G., Padula A. et al. Infliximab in a case of early adult-onset Still's disease. Clin Rheumatol 2003;22:369-70.</p><p>Serratrice J., Granel B., Disdier P. et al. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med 2003;115:589-90.</p><p>Kumari R., Uppal S.S. Prolonged remission in adult-onset Still's disease with etanercept. Clin Rheumatol 2006;25:106-8.</p><p>Asherson R.A., Pascoe L. Adult onset Still's disease: response to Enbrel. Ann Rheum Dis 2002;61:859-60.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheumatol 2005;23:733.</p><p>Haraoui B., Bourrelle D., Kaminska E. Anakinra in the treatmentof adult onset Still's disease. Ann Rheum Dis 2004;63(Suppl.):293-4.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Kalliolias G.D., Georgiou P.E., Antonopoulos I.A. et al. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrial. Ann Rheum Dis 2007;66:842-3.</p><p>Vasques Godinho F.M., Parreira Santos M.J., Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Rudinskaya A., Trock D.H. Successful treatment of a patient with refractory adultonset Still disease with anakinra. J Clin Rheumatol 2003;9:330-2.</p><p>Quartuccio L., De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease. J Rheumatol 2007;34:892-3.</p><p>Chu C., Hughes G., Karr N. et al. Interleukin-1 blockade is an effective treatment of adult onset Still's disease. Arthr Rheum 2005;52:4101.</p><p>Lequerre T., Quartier P., Rosellini D. et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008;67:302-8.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C., Gross W.L. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006;65:1117-8.</p><p>Nakahara H., Mima T., Yoshio-Hoshino N. et al. A case report of a patient with refractory adult onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009;19:69-72.</p><p>De Bandt M., Saint-Marcouux B. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009;68:153-4.</p><p>Priori R., Ceccarelli F., Baqrone F. et al. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Clin Exp Rheumatol 2008;26:933-7.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adultonset Still's disease with anti-CD20 monoclonal antibody. Clin Exp Rheumatol 2009;27:888-9.</p><p>Appenzeller S., Castro G., Costallat L. et al. Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005;11:76-80.</p><p>Arkfeld D.G. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 2008;28:205-15.</p><p>Kong X.D., Xu D., Zhang W. et al. Clinical features and prognosis in adultonset still's disease: a study of 104 cases. Clin Rheumatol 2010;29:1015-9.</p><p>Franchini S., Dagna L., Salvo F. et al. Efficacy of traditional and biological agents in different clinical phenotypes of adultonset Still's disease. Arthr Rheum 2010, Apr 29 [Epub. ahead of print].</p><p>Quartuccio L., Maset M., De Vita S. Efficacy of abatacept in a refractory case of adult-onset Still's disease. Clin Exp Rheumatol 2010;28:265-7.</p><p>Ak O., Ozer S., Cag Y., Karagöz G. An adult onset Still's disease mimicking pneumonia. Rheumatol Int 2010, Apr 2 [Epub. ahead of print].</p><p>Муравьев Ю.В., Жуковская Г.Н., Лебедева В.В. О синдроме Стилла у взрослых. Ревматология 1991;1:37-40.</p><p>Carli L., Rizelli G.M.L., d'Ascanio A. et al. Adult onset Still'disease: analysis of a monocentric cohort. Ann Rheum Dis 2010;69(Suppl. 3):716.</p><p>Salvin S., Quartuccio L., Moroldo T. et al. Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset Still's disease. Ann Rheum Dis 2010;69(Suppl. 3):710.</p><p>Perdan-Pirkmajer K., Praprotnik S., Tomsic M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010, Aug 24 [Epub. ahead of print].</p><p>Kobayashi M., Takahashi Y., Yamashita H. et al. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol 2010, Aug 26 [Epub. ahead of print].</p><p>Sumida K., Ubara Y., Hoshino J. et al. Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 2010, Mar 12 [Epub. ahead of print].</p><p>Matsumoto K., Nagashima T., Takatori S. et al. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 2009;28:485-7.</p><p>Yoshimura M., Makiyama J., Koga T. et al. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD). Clin Exp Rheumatol 2010;28:141-2.</p><p>Puechal X., de Bandt M., Berthelot J.M. et al. Tocilizumab in refractory adult Still's disease. Arthr Care Res (Hoboken) 2010, Aug 25 [Epub. ahead of print].</p></div><br /><div><p>Международная статистическая классификация болезней и проблем, связанных со здоровьем;10-й пересмотр. Женева: ВОЗ, 1995.</p><p>Efthimiou P., Paik P.K., Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.</p><p>Bannatyne G.A., Wohlmann A.S. Rheumatoid Arthritis: Its clinical history, etiology and pathology. Lancet 1896;1:1120-5.</p><p>Still G.F. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-65.</p><p>Reimann H.A., de Bardinis C.T. Periodic cyclic neutropenia, an entity. Blood 1949;4:1109-16.</p><p>Wissler H. Uber eine besondere Form sepsisahnlicher krankheiten (subsepsishyperergica). Z Kinderheilkd 1964;94:1-23.</p><p>Hegglin R., Uehlinger E. Klinische Demonstrationen: Febris periodica hyperergica. Schweiz Med Wschr 1964;94:675-85.</p><p>Fanconi G. Uber einen Fall von Subsepsis allergica Wissler. Helv Paediatr Acta 1946;1:532-7.</p><p>Riolet J. Syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1964;31:388-97.</p><p>Larson E.B. Adult Still's disease - recognition of a clinical syndrome and recent experience. West J Med 1985;142:665-71.</p><p>Wissler H. Subsepsis allergica. Ergeb Inn Med Kinderheilkd 1965;23:202-20.</p><p>Bywaters E.G. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.</p><p>Bywaters E.G. Categorization in medicine: A survey of Still's disease. Ann Rheum Dis 1967;26:185-93.</p><p>Bujak J.S., Aptekar R.G., Decker J.L. et al. Juvenile rheumatoid arthritis in theadult presenting as fever of unknown origin. Medicine (Baltimore) 1973;52:431-44.</p><p>Fabricant M.S., Chander S.B., Friou G.J. Still's disease in adults: A cause of prolonged undiagnosed fever. JAMA 1973;225:273-5.</p><p>Caroit M., Mathieu M., Kahn M.F. et al. Maladie de Still de l'adulte et syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1973;40:1-8.</p><p>Calabro J.J., Marchesano J.M. Fever associated with juvenile rheumatoid arthritis. N Engl J Med 1967;276:1-18.</p><p>Isdaile I.C., Bywaters E.G. The rash in Still's disease. Quart J Med 1956;25:377-87.</p><p>Calabro J.J., Cruess R.L., Levinson J.E. et al. Juvenile rheumatoid arthritis. Patient Care 1977;11:70-116.</p><p>Elkon K.B., Hughes G.R., Bywaters E.G. et al. Adult onset Still's disease: Twenty-year follow-up and further studies of patients with active disease. Arthr Rheum 1982;25:647-53.</p><p>Medsger T.A., Christy W.C. Carpal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1976;19:232-42.</p><p>Healey L.A., Willkens R.F. Tarsal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1982;25:1254-6.</p><p>Jamieson T.W. Adult Still's disease complicated by cardiac tamponade. JAMA 1983;249:2065-6.</p><p>Tesser J.R., Pisko E.J., Hartz J.W. et al. Chronic liver disease and adult Still's disease. Arthr Rheum 1982;25:579-82.</p><p>Baker D.G., Schumacher H.R., Reginato A.J. Fifteen patients with adult onset Still's disease: Life-threatening liver failure in two (Abstr). Arthr Rheum 1979;22:590.</p><p>Masson C., Le Loët X., Liote F. et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 1995;62:748-57.</p><p>Pelkonen P., Swanliung K., Siimes M.A. Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatr Scand 1986;75:64-8.</p><p>Gonzalez-Hernandez T., Martin-Mola E., Femandez-Zamoeano A. et al. Serum ferritin can be useful for diagnosis in adult onset Still's disease. J Rheumatol 1989;16:412-3.</p><p>Fautrel B., Le Moel G., Saint-Marcoux B. et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001;28:322-9.</p><p>Fautrel B. Ferritin levels in adult Still's disease: any sugar? J Bone Spine 2002;69:355-7.</p><p>Cush J.J. Adult-onset Still's disease. Bull Rheum Dis 2000;49:1-4.</p><p>Van Reeth C., Le Moel G., Lasne Y. et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's dis ease. J Rheumatol 1994;21:890-5.</p><p>Akritidis N., Giannakakis I., Giouglis T. Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol 1996;23:201-2.</p><p>Magadur-Joly G., Billaud E., Barrier J.H. et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 1995;54:587-90.</p><p>Wakai K., Ohta A., Tamakoshi A. et al. Estimated prevalence and incidence of adult Still's disease: findings by anationwide epidemiological survey in Japan. J Epidemiol 1997;7:221-5.</p><p>Ohta A., Yamaguchi M., Tsunematsu T. et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.</p><p>Van de Putte L.B., Wouters J.M. Adultonset Still's disease. Bailliere's Clin Rheumatol 1991;5:263-75.</p><p>Wouters J.M., van de Putte L.B. Adultonset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Quart J Med 1986;61:1055-65.</p><p>Sampalis J.S., Medsger T.A., Fries J.F. et al. Risk factors for adult Still's disease. J Rheumatol 1996;23:2049-54.</p><p>Kontzias A., Efthimiou P. Adult-Onset Still's Disease Pathogenesis, Clinical Manifestations and Therapeutic Advances. Drugs 2008;68:319-37.</p><p>Hoshino T., Ohta A., Yang D. et al. Elevated serum interleukin 6, interferongamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 1998;25:396-8.</p><p>Ogata A., Kitano M., Yamanaka J. et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003;30:1093-6.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Jeon Y.K., Paik J.H., Park S.S. et al. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol 2004;57:1052-6.</p><p>Jamin C., Morva A., Lemoine S. et al. Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthr Rheum 2008;58:1900-6.</p><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.</p><p>Cush J.J., Medsger T. Jr., Christy W.C. et al. Adult-onset Still's disease: clinical course and outcome. Arthr Rheum 1987;30:186-94.</p><p>Fautrel B., Zing E., Golmard J.L. et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194-200.</p><p>Pouchot J., Sampalis J.S., Beaudet F. et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-36.</p><p>Evensen K.J., Nossent H.C. Epidemiology and outcome of adult onset Still's disease in northern Norway. Scand J Rheumatol 2006;35:48-51.</p><p>Pay S., Turkcapar N., Kalyoncu M. et al. A multicenter study of patients with adultonset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006;25:639-44.</p><p>Mandl L., Esdaile J.M. Adult Still's disease. Up To Date. <http://www.uptodate.com/> (accessed 14 February 2006).</p><p>Kaplinsky N., Paas M., Frankl О. An adult form of juvenile rheumatoid arthritis. Arch Intern Med 1980;140:1073-4.</p><p>Khraishi M., Fam A.G. Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol 1991;18:1088-90.</p><p>Bambery P., Thomas R.J., Malhotra H.S. et al. Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 1992;51:529-32.</p><p>Shojania K., Chalmers A., Rangno K. Cyclosporin A in thetreatment of adult Still's disease. J Rheumatol 1995;22:1391-2.</p><p>Cefle A. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother 2005;39:764-7.</p><p>Murakami K., Fujii T., Yukawa N. et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. The Japan Rheum. Association. Modern Rheumatol 2007;17:167-70.</p><p>Mahmud T., Hughes G.R. Intravenous immunoglobulin in thetreatment of refractory adult Still's disease. J Rheumatol 1999;26:2067-8.</p><p>Vignes S., Wechsler B., Amoura Z. et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal antiinflammatory drugs. Clin Exp Rheumatol 1998;16:295-8.</p><p>Bennett A.N., Peterson P., Sangle S. et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 2004;43:795-9.</p><p>Husni M.E., Maier A.L., Mease P.J. et al. Etanercept in the treatment of adult patients with Still's disease. Arthr Rheum 2002;46:1171-6.</p><p>Kuek A., Weerakoon A., Ahmed K. et al. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford) 2007;46:1043-4.</p><p>Cavagna L., Caporali R., Epis O. et al. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001;19:329-32.</p><p>Kokkinos A., Iliopoulos A., Greka P. et al. Successful treatment of refractory adultonset Still's disease with infliximab: a prospective, non-comparative series of four patients. Clin Rheumatol 2004;23:45-9.</p><p>Huffstutter J., Sienknecht C. Treatment of resistant adult Still's disease with infliximab: a report of 2 cases. J Clin Rheumatol 2004;10:218-21.</p><p>Bonilla Hernan M.G., Cobo Ibanez T., de Miguel Mendieta E. et al. Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease: experience in 2 cases [in Spanish]. Ann Med Interna 2004;21:23-6.</p><p>Caramaschi P., Biasi D., Carletto A. et al. A case of adult onset Still's disease treated with infliximab [letter]. Clin Exp Rheumatol 54. 54. 64</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005;64:262-6.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheum 2005;23:733.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of adult onset Still's disease. Semin Arthr Rheum 2006;36:144-52.</p><p>Godinho F., Santos M.J., Canas Da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Fitzgerald A.A., Leclercq S.A., Yan A. et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthr Rheum 2005;52:1794-803.</p><p>Iwamoto M., Nara H., Hirata D. et al. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthr Rheum 2002;46:3388-9.</p><p>Kraetsch H.G., Antoni C., Kalden J.R. et al. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 2001;60(Suppl. 3):55-7.</p><p>Dechant C., Schauenberg P., Antoni C.E. et al. Long-term out come of TNF blockade in adult-onset Still's disease [in German]. Dtsch Med Wschr 2004;129:1308-12.</p><p>Dilhuydy M.S., Vatan R., Etienne G. et al. Prolonged efficacy of infliximab for refractory adult-onset Still's disease. Clin Exp Rheumatol 2005;23:121-2.</p><p>Michel M., Duvoux C., Hezode C. et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003;30:1624-5.</p><p>Olivieri I., de Stefano G., Padula A. et al. Infliximab in a case of early adult-onset Still's disease. Clin Rheumatol 2003;22:369-70.</p><p>Serratrice J., Granel B., Disdier P. et al. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med 2003;115:589-90.</p><p>Kumari R., Uppal S.S. Prolonged remission in adult-onset Still's disease with etanercept. Clin Rheumatol 2006;25:106-8.</p><p>Asherson R.A., Pascoe L. Adult onset Still's disease: response to Enbrel. Ann Rheum Dis 2002;61:859-60.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheumatol 2005;23:733.</p><p>Haraoui B., Bourrelle D., Kaminska E. Anakinra in the treatmentof adult onset Still's disease. Ann Rheum Dis 2004;63(Suppl.):293-4.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Kalliolias G.D., Georgiou P.E., Antonopoulos I.A. et al. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrial. Ann Rheum Dis 2007;66:842-3.</p><p>Vasques Godinho F.M., Parreira Santos M.J., Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Rudinskaya A., Trock D.H. Successful treatment of a patient with refractory adultonset Still disease with anakinra. J Clin Rheumatol 2003;9:330-2.</p><p>Quartuccio L., De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease. J Rheumatol 2007;34:892-3.</p><p>Chu C., Hughes G., Karr N. et al. Interleukin-1 blockade is an effective treatment of adult onset Still's disease. Arthr Rheum 2005;52:4101.</p><p>Lequerre T., Quartier P., Rosellini D. et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008;67:302-8.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C., Gross W.L. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006;65:1117-8.</p><p>Nakahara H., Mima T., Yoshio-Hoshino N. et al. A case report of a patient with refractory adult onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009;19:69-72.</p><p>De Bandt M., Saint-Marcouux B. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009;68:153-4.</p><p>Priori R., Ceccarelli F., Baqrone F. et al. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Clin Exp Rheumatol 2008;26:933-7.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adultonset Still's disease with anti-CD20 monoclonal antibody. Clin Exp Rheumatol 2009;27:888-9.</p><p>Appenzeller S., Castro G., Costallat L. et al. Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005;11:76-80.</p><p>Arkfeld D.G. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 2008;28:205-15.</p><p>Kong X.D., Xu D., Zhang W. et al. Clinical features and prognosis in adultonset still's disease: a study of 104 cases. Clin Rheumatol 2010;29:1015-9.</p><p>Franchini S., Dagna L., Salvo F. et al. Efficacy of traditional and biological agents in different clinical phenotypes of adultonset Still's disease. Arthr Rheum 2010, Apr 29 [Epub. ahead of print].</p><p>Quartuccio L., Maset M., De Vita S. Efficacy of abatacept in a refractory case of adult-onset Still's disease. Clin Exp Rheumatol 2010;28:265-7.</p><p>Ak O., Ozer S., Cag Y., Karagöz G. An adult onset Still's disease mimicking pneumonia. Rheumatol Int 2010, Apr 2 [Epub. ahead of print].</p><p>Муравьев Ю.В., Жуковская Г.Н., Лебедева В.В. О синдроме Стилла у взрослых. Ревматология 1991;1:37-40.</p><p>Carli L., Rizelli G.M.L., d'Ascanio A. et al. Adult onset Still'disease: analysis of a monocentric cohort. Ann Rheum Dis 2010;69(Suppl. 3):716.</p><p>Salvin S., Quartuccio L., Moroldo T. et al. Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset Still's disease. Ann Rheum Dis 2010;69(Suppl. 3):710.</p><p>Perdan-Pirkmajer K., Praprotnik S., Tomsic M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010, Aug 24 [Epub. ahead of print].</p><p>Kobayashi M., Takahashi Y., Yamashita H. et al. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol 2010, Aug 26 [Epub. ahead of print].</p><p>Sumida K., Ubara Y., Hoshino J. et al. Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 2010, Mar 12 [Epub. ahead of print].</p><p>Matsumoto K., Nagashima T., Takatori S. et al. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 2009;28:485-7.</p><p>Yoshimura M., Makiyama J., Koga T. et al. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD). Clin Exp Rheumatol 2010;28:141-2.</p><p>Puechal X., de Bandt M., Berthelot J.M. et al. Tocilizumab in refractory adult Still's disease. Arthr Care Res (Hoboken) 2010, Aug 25 [Epub. ahead of print].</p></div><br />
The authors declare that there are no conflicts of interest present.